Smart-4-Fabry is the acronym of a H2020 funded Project
that stands for “Smart functional GLA-nanoformulation
for Fabry disease”. Smart-4-Fabry is a collaborative project
funded under the H2020 EU Research
and Innovation programme.
The project started on
the 1st January 2017 and will last four years.
“Personalized Medicines, Targeted Therapies, Precision Drug Delivery” 6th – ...
The project was present in Austria for the Rare Diseases day 2019. The presentation of the...
Smart4Fabry partners from CIBER-VHIR, led by Dr. Ibane Abasolo, had a relevant presence at...